Thumbnail Image
Publication

Corrigendum to Addition of docetaxel to hormonal therapy in low- and high-burden metastatic hormone sensitive prostate cancer: long-term survival results from the STAMPEDE trial: Ann Oncol 2019; 30: 1992-2003

; 
Ali, Adnan
; 
Ingleby, FC
; 
Hoyle, Alex P
; 
Amos, CL
; 
Attard, G
; 
Brawley, CD
; 
Calvert, J
; 
Chowdhury, S
; 
Cook, A
... show 10 more
Citations
Altmetric:
Abstract
Addition of docetaxel to hormonal therapy in low- and high-burden metastatic hormone sensitive prostate cancer: long-term survival results from the STAMPEDE trial. [Ann Oncol. 2019]
Authors
Clarke, Noel W
Ali, Adnan
Ingleby, FC
Hoyle, Alex P
Amos, CL
Attard, G
Brawley, CD
Calvert, J
Chowdhury, S
Cook, A
Cross, W
Dearnaley, D
Douis, H
Gilbert, D
Gillessen, Silke
Jones, RJ
Langley, RE
MacNair, A
Malik, Z
Mason, MD
Matheson, D
Millman, R
Parker, CC
Ritchie, AWS
Rush, H
Russell, JM
Brown, J
Beesley, S
Birtle, A
Capaldi, L
Gale, J
Gibbs, S
Lydon, A
Nikapota, A
Omlin, A
O'Sullivan, JM
Parikh, O
Protheroe, A
Rudman, S
Srihari, NN
Simms, M
Tanguay, JS
Tolan, S
Wagstaff, J
Wallace, J
Wylie, James P
Zarkar, A
Sydes, MR
Parmar, MKB
James, ND
Affiliation
Department of Urology, The Christie and Salford Royal NHS Foundation Trusts, Manchester
Description
Date
2020
Publisher
Collections
All Christie Publications
Show all metadata
Files
Thumbnail Image
From UNPAYWALL
Adobe PDF, 129.02 KB
Keywords
Type
Article
Citation
Clarke NW, Ali A, Ingleby FC, Hoyle A, Amos CL, Attard G, et al. Corrigendum to Addition of docetaxel to hormonal therapy in low- and high-burden metastatic hormone sensitive prostate cancer: long-term survival results from the STAMPEDE trial: Ann Oncol 2019; 30: 1992-2003. Ann Oncol. 2020;31:442.
Journal Title
Journal ISSN
Volume Title
URI
http://hdl.handle.net/10541/622814
Embedded videos